GRTS - Gritstone Oncology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

GRTS is currently covered by 4 analysts

Gritstone Oncology's activity chart (see below) currently has 4 price targets and 13 ratings on display. The stock rating distribution of GRTS is 90.91% BUY and 9.09% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 27.38% of the time, taking 73.33 days on average.

Highest price target for GRTS is $4, Lowest price target is $1.

Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 07-Dec-2023. First documented stock forecast 11-Dec-2018.

Best performing analysts who are covering GRTS - Gritstone Oncology:

Thomas Shrader Madhu Kumar Corinne Jenkins Sean Lee Edward Tenthoff Mayank Mamtani

Currently out of the existing stock ratings of GRTS, 10 are a BUY (90.91%), 1 are a SELL (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$6

$8

2 years 11 months 14 days ago
(07-Dec-2023)

0/2 (0%)

$4.38 (270.37%)

Buy

$7

$6

3 years 1 months 24 days ago
(28-Sep-2023)

0/2 (0%)

$5.44 (348.72%)

Buy

$7

$7

3 years 3 months 11 days ago
(10-Aug-2023)

1/7 (14.29%)

$5.18 (284.62%)

5

Sell

$2

$15

4 years 2 months 30 days ago
(22-Aug-2022)

1/2 (50%)

$-1.74 (-46.52%)

267

Buy

$35

5 years 1 months 6 days ago
(15-Oct-2021)

0/2 (0%)

$9.45 (36.99%)

Show more analysts

Please expand the browser size to see the chart

What is GRTS (Gritstone Oncology) average time for price targets to be met?

On average it took 73 days for the stock forecasts to be reached, with an average price target met ratio of 27.38%.

Which analyst most recently updated their price target on GRTS (Gritstone Oncology)?

Mayank Mamtani

Which analyst has the lowest performance score on GRTS (Gritstone Oncology) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on GRTS (Gritstone Oncology)?

Mayank Mamtani works at B. RILEY and has 5 price targets and 4 ratings on GRTS

Which analyst is the currently most bullish on GRTS (Gritstone Oncology)?

Sean Lee with the highest potential upside of $5.99

Which analyst is the currently most reserved on GRTS (Gritstone Oncology)?

Thomas Shrader with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?